pyrroles has been researched along with Sarcoidosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, ZS; Liu, QP; Wei, JC; Xu, Q | 1 |
| Deguchi, N; Kawamura, T; Mitsui, H; Muto, Y; Ogawa, Y; Shimada, S | 1 |
| Damsky, W; Emeagwali, N; Galan, A; King, B; Thakral, D | 1 |
| Damsky, W; Galan, A; King, B; Leventhal, J; McGeary, MK; Thakral, D | 1 |
4 other study(ies) available for pyrroles and Sarcoidosis
| Article | Year |
|---|---|
Tofacitinib for sarcoidosis, a new potential treatment.
Topics: Humans; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sarcoidosis | 2022 |
Case of cutaneous sarcoidosis treated with delgocitinib 0.5% ointment.
Topics: Emollients; Humans; Ointments; Pyrroles; Sarcoidosis; Skin Diseases | 2021 |
Tofacitinib Treatment and Molecular Analysis of Cutaneous Sarcoidosis.
Topics: Female; Humans; Immunohistochemistry; Janus Kinases; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Remission Induction; Sarcoidosis; Sarcoidosis, Pulmonary; Sequence Analysis, RNA; Signal Transduction; Skin; Skin Diseases; STAT Transcription Factors | 2018 |
Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.
Topics: Adult; Aged; Biopsy; Female; Granuloma Annulare; Humans; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Prospective Studies; Pyrimidines; Pyrroles; Remission Induction; Sarcoidosis; Severity of Illness Index; Skin; Treatment Outcome | 2020 |